Abbott Labs

$126.05 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Abbott Labs

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products, including FreeStyle, PediaSure, Pedialyte, Similac, EleCare, ZonePerfect, Juven, Ensure and Glucerna. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. The cardiovascular's products include Portico, MitraClip, Dilatation Catheter, among others. The diagnostics products include IntelliFISH, Vysis ALK, STARLIMS, PathVysion, AlinIQ, among others.

Stock Analysis

last close $126.57
1-mo return -7.7%
3-mo return 8.3%
avg daily vol. 5.23M
52-week high 142.6
52-week low 105.36
market cap. $226.6B
forward pe 27
annual div. 1.88
roe 22%
ltg forecast 13.1%
dividend yield 1.49%
annual rev. $42.3B
inst own. 75.4%
baraka

Subscribe now for daily local and international financial news

Subscribe